Detalhe da pesquisa
1.
A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer.
Eur J Nucl Med Mol Imaging
; 51(3): 871-882, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37864592
2.
68Ga-DOTATATE PET/CT Detected Bone Metastasis Earlier Than 68Ga-FAPI PET/CT and 99mTc-MDP Bone Scintigraphy in a Patient With Nasopharyngeal Carcinoma.
Clin Nucl Med
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768089